Human Parvovirus B19 Infection in Persons with Haemophilia

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 1998; 80(02): 351
DOI: 10.1055/s-0037-1615208

Letters to the Editor

Schattauer GmbH

Authors

C. Prowse

¹SNBTS National Science Laboratory, Edinburgh
B. Dow

²SNBTS Microbiology Reference Unit
S. J. Pelly

³SNBTS Product Services Department
E. McIntosh

³SNBTS Product Services Department
S. Reading

³SNBTS Product Services Department
G. D. O. Lowe

⁴Department of Medicine, Royal Infirmary, Glasgow
B. Gibson

⁵Royal Hospital for Sick Children, Glasgow
P. Cachia

⁶Ninewells Hospital, Dundee
A. Thomas

⁷Royal Hospital for Sick Children, Edinburgh and Royal Infirmary, Edinburgh, UK
R. Dennis

⁸Royal Infirmary, Edinburgh, UK
C. A. Ludlam

⁸Royal Infirmary, Edinburgh, UK

Received 10 February 1998

Accepted 09 April 1998

Publication Date:
08 December 2017 (online)

References
1 Aygören-Pürsün E, Scharrer I. German Kogenate Study Group.. A multicentre pharmacosurveillance study for the evaluation of the efficacy and safety of recombinant Factor VIII in the treatment of patients with haemophilia A.. Thromb Haemost 1998; 78: 1352-6.

Reference Link Ris
Thieme Connect PubMed Search in Google Scholar
2 Prowse CV. Parvovirus B19 and blood products.. Lancet 1994; 343: 1101.

Reference Link Ris
Crossref PubMed Search in Google Scholar
3 Prowse CV, Ludlam CA, Yap PL. Human parvovirus B19 and blood products.. Vox Sang, 1998; 72: 1-10.

Reference Link Ris
PubMed Search in Google Scholar
4 Prowse CV, Dow B, Pelly J. et al. Studies on B19 parvovirus in the normal and haemophilic. Scottish population in 1995.. Thromb Haemost 1998; Suppl: 455 (PS-1857).

Reference Link Ris
Thieme Connect PubMed Search in Google Scholar
5 Williams MD, Cohen BJ, Beddall AC, Pasi RJ, Mortimer P, Hill FGW. Transmission of human parvovirus B19 by coagulation factor concentrates.. Vox Sang 1990; 58: 177-81.

Reference Link Ris
Crossref PubMed Search in Google Scholar